Explore
← New search
Filters:
partial
✕
cell viability assay
✕
primary mf/saml patient cd34+ cells; pdx model (patient 784981)
✕
clear all
1 matching publication(s)
RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia.
PMID 39820365 · Nat Commun · 2025
L1
73/100